Trademark: 97341559
Status Date
Tuesday, December 5, 2023
Registration Number
7237702
Registration Date
Tuesday, December 5, 2023
Filing Date
Thursday, March 31, 2022
Published for Opposition
Tuesday, May 23, 2023
44 Genetic testing for medical purposes; Consulting services in the field of genetic testing for medical purposes; Medical and health services relating to DNA, RNA, genetics, genetic testing and genetic sequencing in the field of oncology; Providing medical information via the preparation of medical reports, namely, diagnostic reports based on genetic tumor profile; Providing medical information via medical reports, namely, clinical reports providing disease treatment recommendations and information about disease treatment and prognosis; Providing medical information to healthcare professionals on cancer diagnostics, treatment and prognosis; Providing medical information via a website featuring information on patient genetic data for diagnosis and treatment purposes; Medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Medical laboratory services for the analysis of samples taken from patients, namely, analysis of biological tumor sample and genetic sequencing; Pathology services relating to the treatment of persons, namely, analysis of biological tumor sample for medical purposes; Laboratory testing services, namely, genetic testing in the field of oncology for analyzing, classifying, interpreting and diagnosing genetic data for medical diagnostic and treatment purposes
10 Medical apparatus and instrument for diagnostic use, namely, apparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testing, cytology and cell-based testing; Genetic testing apparatus for medical purposes; Diagnostic kits comprising of test tubes, collection containers and tools, for collecting biological samples for use in medical testing
42 Scientific laboratory services in the field of genomics, namely, genetic sequencing, analysis and diagnosis of biological tumor sample; Platform as a Services (PAAS) featuring computer software platforms for analyzing, classifying, interpreting and diagnosing genetic data; Platform as a Services (PAAS) featuring computer software platforms that provide a diagnostic report based on genetic tumor profile; Platform as a Services (PAAS) featuring computer software platforms for analyzing genetic data and providing healthcare professionals information about a patient's diagnosis, prognosis and treatment recommendations
Dec 5, 2023
Notice Of Registration Confirmation Emailed
Dec 5, 2023
Registered-Principal Register
Nov 2, 2023
Notice Of Acceptance Of Statement Of Use E-Mailed
Nov 1, 2023
Allowed Principal Register - Sou Accepted
Sep 13, 2023
Notice Of Approval Of Extension Request E-Mailed
Sep 12, 2023
Statement Of Use Processing Complete
Aug 30, 2023
Use Amendment Filed
Sep 12, 2023
Sou Extension 1 Granted
Aug 30, 2023
Sou Extension 1 Filed
Sep 8, 2023
Case Assigned To Intent To Use Paralegal
Aug 30, 2023
Sou Teas Extension Received
Aug 30, 2023
Teas Statement Of Use Received
Jul 18, 2023
Noa E-Mailed - Sou Required From Applicant
May 23, 2023
Official Gazette Publication Confirmation E-Mailed
May 23, 2023
Published For Opposition
May 3, 2023
Notification Of Notice Of Publication E-Mailed
Apr 20, 2023
Approved For Pub - Principal Register
Apr 19, 2023
Teas/Email Correspondence Entered
Apr 18, 2023
Correspondence Received In Law Office
Apr 18, 2023
Teas Request For Reconsideration Received
Apr 10, 2023
Notification Of Final Refusal Emailed
Apr 10, 2023
Final Refusal E-Mailed
Apr 10, 2023
Final Refusal Written
Mar 21, 2023
Teas/Email Correspondence Entered
Mar 21, 2023
Correspondence Received In Law Office
Mar 21, 2023
Teas Response To Office Action Received
Jan 26, 2023
Notification Of Priority Action E-Mailed
Jan 26, 2023
Priority Action E-Mailed
Jan 26, 2023
Priority Action Written
Jan 17, 2023
Assigned To Examiner
Apr 6, 2022
New Application Office Supplied Data Entered
Apr 4, 2022
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
